neal ryan editorial month american journal psychiatry dr ryan noted academic child psychiatrist played role infamous paxil study obfuscated findings paxil possessed little efficacy relative placebo carried risk placebo terms suicidal thoughts attempts aggressive behavior summary excellent panorama expose study included following snippet child psychiatrist dr neal ryan university pittsburgh paid gsk co author study also gave talk childhood depression medical conference sponsored gsk said seroxat could suitable treatment children later told panorama reporter shelley jofre probably lowered rather raised suicide rates amongst archive emails malibu shelley surprised find emails dr ryan asking questions safety seroxat forwarded gsk asking advice respond also found email public relations executive working gsk said originally planned extensive media relations surrounding study actually viewed results essentially study really show effective treating adolescent depression something want publicise ryan changed tune writes latest american journal psychiatry trial fluoxetine prozac treatment children adolescents depression piece begins background information newer antidepressants single controlled trial showing efficacy treatment major depression youths thus far studies several antidepressants shown statistical superiority placebo well designed trials population cites one source bridge et al support statement i checked source clear table etable precise source single trial showing superiority drug placebo paxil study coauthored ryan paroxetine generally well tolerated effective major depression adolescents p yet saying antidepressants paxil effective treating depression note dr ryan specifically retract earlier claims efficacy paxil current statement certainly contradict prior writing wonders paxil well fair statement efficacy paroxetine could well ghostwritten know good majority paper written ghostwriters employ glaxosmithkline end current editorial stated dr ryan received research support nimh reports competing interests dr ryan participate paxil study free i would guess indeed received funding gsk efforts study perhaps i wrong actually peripheral point main point ryan never disavowed overstatement efficacy minimization risk occurred published study report paxil findings yet pens editorial states antidepressants except prozac possess efficacy treating child adolescent depression either paxil works work dr ryan ways still waiting first key opinion leader admit frankly efficacy claims made paxil inaccurate